Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

BBIO

BridgeBio Pharma Inc

May 29 • 02:17PM ET

66.85

-1.60 -2.34 %

Healthcare • Biotechnology • USA • Large • NASD

Peers: ASND BMRN MDGL ALNY IONS KRYS EXEL RARE ARWR VRTX

| Held by: VTI VB IWM VBK VXF XBI IWO IBB VTWO SCHA

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-3.75	Insider Own	13.74%	Shs Outstand	195.71M	Perf Week	-4.88%
Market Cap	13.09B	Forward P/E	108.22	EPS next Y	0.62	Insider Trans	-2.60%	Shs Float	169.02M	Perf Month	-5.76%
Enterprise Value	15.55B	PEG	-	EPS next Q	-0.59	Inst Own	91.01%	Short Float	14.30%	Perf Quarter	0.56%
Income	-721.55M	P/S	22.58	EPS this Y	42.04%	Inst Trans	5.84%	Short Ratio	10.04	Perf Half Y	-5.35%
Sales	579.96M	P/B	-	EPS next Y	128.20%	ROA	-64.06%	Short Interest	24.16M	Perf YTD	-12.60%
Book/sh	-11.64	P/C	13.92	EPS next 5Y	-	ROE	-	52W High	84.94 -21.30%	Perf Year	100.33%
Cash/sh	4.80	P/FCF	-	EPS past 3/5Y	-5.07% 0.09%	ROIC	-135.35%	52W Low	31.77 110.42%	Perf 3Y	386.19%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	86.30% 127.44%	Gross Margin	94.69%	Volatility	4.57% 4.33%	Perf 5Y	12.92%
Dividend TTM	-	EV/Sales	26.81	EPS Y/Y TTM	-6.09%	Oper. Margin	-86.94%	ATR (14)	3.14	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	1.48	Sales Y/Y TTM	355.17%	Profit Margin	-124.41%	RSI (14)	44.85	Recom	1.38
Dividend Gr. 3/5Y	- -	Current Ratio	1.52	EPS Q/Q	4.35%	SMA20	-1.16%	Beta	0.99	Target Price	104.67
Payout	-	Debt/Eq	-	Sales Q/Q	66.78%	SMA50	-5.83%	Rel Volume	0.75	Prev Close	68.45
Employees	839	LT Debt/Eq	-	Earnings	May 07 AMC	SMA200	0.72%	Avg Volume	2.41M	Price	66.85
IPO	Jun 27, 2019	Option/Short	Yes / Yes	EPS/Sales Surpr.	-23.75% 9.24%	Trades		Volume	1,353,837	Change	-2.34%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)